ATE414282T1 - Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum - Google Patents

Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum

Info

Publication number
ATE414282T1
ATE414282T1 AT03793839T AT03793839T ATE414282T1 AT E414282 T1 ATE414282 T1 AT E414282T1 AT 03793839 T AT03793839 T AT 03793839T AT 03793839 T AT03793839 T AT 03793839T AT E414282 T1 ATE414282 T1 AT E414282T1
Authority
AT
Austria
Prior art keywords
value
marker
individual
cut
pepsinogen
Prior art date
Application number
AT03793839T
Other languages
English (en)
Inventor
Osmo Suovaniemi
Matti Haerkoenen
Pentti Sipponen
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Application granted granted Critical
Publication of ATE414282T1 publication Critical patent/ATE414282T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56922Campylobacter
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/595Gastrins; Cholecystokinins [CCK]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03793839T 2002-09-06 2003-09-05 Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum ATE414282T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20021598A FI119571B (fi) 2002-09-06 2002-09-06 Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä

Publications (1)

Publication Number Publication Date
ATE414282T1 true ATE414282T1 (de) 2008-11-15

Family

ID=8564544

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03793839T ATE414282T1 (de) 2002-09-06 2003-09-05 Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum

Country Status (10)

Country Link
EP (1) EP1552311B1 (de)
JP (1) JP4261481B2 (de)
KR (1) KR101108282B1 (de)
CN (1) CN1682115A (de)
AT (1) ATE414282T1 (de)
AU (1) AU2003260530A1 (de)
DE (1) DE60324698D1 (de)
EA (1) EA007003B1 (de)
FI (1) FI119571B (de)
WO (1) WO2004023148A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002076499A2 (en) 2001-03-23 2002-10-03 Aphton Corporation Combination treatment of pancreatic cancer
US20090191232A1 (en) 2001-05-04 2009-07-30 Gevas Philip C Combination therapy for the treatment of tumors
EP1608984A2 (de) 2003-03-28 2005-12-28 Aphton Corporation Gastrin hormon immunoassays
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
JP2008513536A (ja) 2004-09-22 2008-05-01 レセプター バイオロジックス インコーポレイテッド プロガストリンに対するモノクローナル抗体
FI20060501A7 (fi) * 2006-05-22 2007-11-23 Biohit Oyj Koostumus ja menetelmä asetaldehydin sitomiseksi mahalaukussa
WO2011161301A1 (en) 2010-06-24 2011-12-29 Valtion Teknillinen Tutkimuskeskus State inference in a heterogeneous system
FI20145550A7 (fi) * 2014-06-13 2015-12-14 Biohit Oyj Gastriini-17 käyttö biomarkkerina atrofiselle gastriitille ja usealle sen seurauksena kohonneelle riskille
IL271427B2 (en) 2017-06-15 2025-08-01 Cancer Advances Inc Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
US12150978B2 (en) 2017-06-15 2024-11-26 Cancer Advances Inc. Compositions and methods for preventing tumors and cancer
KR102637908B1 (ko) * 2018-12-28 2024-02-20 씨제이제일제당 (주) 헬리코박터 파일로리 연관 질환에 대한 유전자 마커

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
FI20010019L (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi

Also Published As

Publication number Publication date
EA200500449A1 (ru) 2005-08-25
FI119571B (fi) 2008-12-31
KR20050057220A (ko) 2005-06-16
CN1682115A (zh) 2005-10-12
FI20021598L (fi) 2004-03-07
AU2003260530A1 (en) 2004-03-29
JP2005538348A (ja) 2005-12-15
EA007003B1 (ru) 2006-06-30
KR101108282B1 (ko) 2012-01-31
EP1552311B1 (de) 2008-11-12
DE60324698D1 (de) 2008-12-24
EP1552311A1 (de) 2005-07-13
FI20021598A0 (fi) 2002-09-06
JP4261481B2 (ja) 2009-04-30
WO2004023148A1 (en) 2004-03-18

Similar Documents

Publication Publication Date Title
WO2002054084A8 (en) A method for diagnosing atrophic gastritis
ATE230801T1 (de) Verfahren zur detektion von zielnukleinsäure, verfahren zu ihrer quantifizierung und pyrylium- verbindungen zur chemilumineszenz-analyse
ATE414282T1 (de) Verfahren zum nachweis eines risikos einer säureassoziierten krankheit in einem individuum
ATE508360T1 (de) Verfahren, vorrichtungen und computerprogramme zum verifizieren der integrität einer sonde
WO2006126008A3 (en) Improved immunoassay methods
NO20061498L (no) Fremgangsmate for bestemmelse av inneholdet av minst en gitt gass i en boreslam
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
ATE335850T1 (de) Echtzeit-quantifizierung mit internen standards
DE60021369D1 (de) Verfahren zur abschätzung eines magengeschwür-risikos
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DK1882946T3 (da) Fremgangsmåde til at bedømme rheumatold arthritis ved at måle anti-CCP og interleukin 6
ATE436015T1 (de) Verfahren, chip, vorrichtung und integriertes system zum nachweis biologischer partikel
ATE478337T1 (de) Methoden zum nachweis analyten in proben
DE60307337D1 (de) Verfahren zur Identifizierung von Umweltkontaminationen durch Detektion von Enteroviren
WO2005081783A3 (en) Method for determination and quantification of radiation or genotoxin exposure
WO2002077645A3 (en) Method for the measurement of soluble analytes
DE50115503D1 (de) Verfahren und mittel zur bestimmung von gesamthärte
ATE344839T1 (de) Verfahren zum nachweis von arsenionen durch indikatorbakterien
ATE495267T1 (de) Diagnostisches verfahren zum nachweis von helicobacter pylori
ATE232981T1 (de) Differenziertes timingsverfahren zum nachweiss multiple analyte in eine testprobe
ATE455297T1 (de) Mikrosensor zur bestimmung von d-aminosäuren
ATE430938T1 (de) Verfahren zur vorhersage des zustands der magenschleimhaut
DK0677589T3 (da) Fremgangsmåde, testelement og testkit til semikvntitativ påvisning af mål-nucleinsyre
DE60317497D1 (de) Verfahren, system und kit zum nachweis eines analyten in einer probe
GB0304832D0 (en) Assay method

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties